402. The Opioid Tragedy, Part 1: “We’ve Addicted an Entire Generation”

Episode Summary

Executive Summary: This episode traces the opioid crisis from overprescribing and the medicalization of pain to the rise of heroin and fentanyl. It shows how insurers, regulators, pharma marketing, and easy access to leftover pills created supply-induced demand, while addiction then drove users into illicit markets. It also highlights new ER and pharmacy interventions, but emphasizes the crisis remains unresolved.

Main Topics: Clinical response in the ER (Priority: 5/5): UPenn’s emergency department pairs doctors with a recovering-addict recovery specialist to triage patients in withdrawal or seeking treatment, aiming to reduce barriers and improve trust. How pain became the 'fifth vital sign' (Priority: 5/5): The episode argues that hospital accreditation pressure, lobbying, and pharmaceutical influence normalized aggressive pain treatment and led doctors to prescribe opioids more liberally. From prescription opioids to heroin and fentanyl (Priority: 5/5): The crisis is framed as three waves: prescription opioid overuse, then heroin, then synthetic fentanyl, with many users moving from legal pills to street drugs after access was restricted. Supply-induced demand and pharmaceutical incentives (Priority: 4/5): Purdue Pharma, advocacy groups, and government subsidy mechanisms are presented as key forces that expanded opioid availability and lowered price, effectively encouraging dependence. Leftover pills and diversion (Priority: 4/5): A major source of misuse is the surplus pills left in medicine cabinets, which are often taken by family members, friends, or sold on the black market. Policy, lawsuits, and public health interventions (Priority: 4/5): The episode reviews prescribing limits, monitoring programs, litigation against drug makers and distributors, and experimental buyback programs designed to reduce unused opioids. Demographics and geography of harm (Priority: 3/5): The discussion highlights high impact in Philadelphia, Massachusetts, rural areas, low-income communities, and among men ages 25-34, with notable racial disparities in prescribing patterns.

Key Arguments: The opioid crisis was not inevitable; it was shaped by policy, medical culture, marketing, and subsidies that expanded prescribing beyond what was clinically necessary. Treating pain as a vital sign encouraged overprescribing because pain is subjective and opioids are uniquely reinforcing compared with other medications. Most heroin users began with prescription opioids, making the legal and illegal opioid markets part of the same pipeline. When prescription access tightened, many dependent users shifted to heroin and later fentanyl, which is stronger and deadlier. A large share of opioid misuse comes from diverted pills already prescribed to someone else, not just new prescriptions to the eventual user. ER-based treatment and recovery specialists can improve engagement, but structural barriers—especially methadone rules—still limit effective care. Financial incentives and take-back programs may reduce unused pills, but early results show modest return rates and no guarantee of large-scale impact. The crisis carries enormous economic costs through healthcare, lost productivity, policing, and incarceration, not just mortality.

Data Points: UPenn patient volume: 1,000 to 1,200 patients per year - Patients visiting UPenn's three hospitals in a year UPenn overdoses: about 400 per year - Among annual UPenn hospital patients UPenn treatment-seeking patients: about 200 to 300 per year - Patients seeking addiction treatment UPenn treatment for complications: about 400 per year - Skin infections, fevers, abdominal pain, nausea, vomiting, withdrawal U.S. overdose deaths in 2017: about 70,000 - Total drug overdose deaths referenced in the episode U.S. overdose deaths last year: at least 64,000 - Deaths cited as the prior year's toll Annual economic cost of prescription opioid abuse: nearly $80 billion - CDC estimate including healthcare, treatment, productivity, policing, incarceration Philadelphia overdose vs homicide: twice as many - One recent year, drug overdoses exceeded homicides by a factor of two Estimated heroin/opioid addiction in Philadelphia: 75,000 people - City health department estimate Share of heroin users who started with prescription opioids: roughly 80% - Pathway from prescribed opioids to heroin use Risk after 30-day opioid supply: 30% still on opioids at 6 months - Discussion of long-term use after a larger prescription Risk after 10-12 pills: 6% still on opioids at 6 months - Discussion of long-term use after a smaller prescription Annual opioid deaths in Massachusetts: about 2,000 - Deaths related to opioids, with overlap across categories Massachusetts synthetic opioid deaths: about 1,600 - Primarily fentanyl-related deaths Massachusetts heroin deaths: about 450 - Heroin-related deaths Massachusetts prescription opioid deaths: about 350 - Prescription opioid-related deaths Price decline of opioids: 81% decline from 2001 to 2010 - Linked to government subsidy and expanded prescribing Purdue OxyContin sales: $48 million in 1996 to $1.1 billion four years later - Rapid market growth after launch Prescription fill prevalence: more than 1 in 5 Americans in 2017 - People with at least one filled opioid prescription Average number of prescriptions per patient: about 3.4 - Among Americans who had an opioid prescription filled Medical exposure after sprained ankle: up to 40% received opioids - UPenn study on ER treatment of ankle sprains Take-back kiosk usage: about 10% of patients - Estimated use rate where kiosks are available Buyback pilot return rate: about 5% - Early Massachusetts buyback program results Buyback incentive effect: three quarters of returns came from incentivized site - Preliminary evidence from the pilot Street price per pill: about $20 per pill - Black market price mentioned in buyback discussion How abusers obtain pills: about 50% from family/friends - Diversion from medicine cabinets Improper disposal share: about half of those family/friend sources - Medication found in medicine cabinets Bought from relative: about 10% - Users paying relatives to obtain pills Stolen from relative: about 5% - Users outright stealing pills Global opioid consumption: more than 80% of the world's opioids - U.S. share despite having 4.4% of world population World population share: 4.4% - U.S. share of global population

Pivotal Quotes: "They really somehow fooled us into thinking that pain was a vital sign as well and that we needed to treat it more liberally." — Jean-Marie Perrone: Explaining how pain scoring and hospital pressure drove overprescribing "What they implicitly did was to subsidize the growth of an addictive substance as opposed to tax it." — Thomas Philipson: Describing Medicare Part D and the economics of opioid expansion "There's no way to get through the day without taking the pill." — Stephen Lloyd: Describing the compulsive, withdrawal-driven nature of opioid addiction

Implications: The episode suggests the crisis is a policy-and-system failure as much as a medical one. Better prescribing rules, disposal systems, and treatment access help, but meaningful progress also requires confronting the incentives that created widespread dependence and the fentanyl supply now filling the gap.